... the fourth medicine cleared for sale with abuse-deterrent labeling. The FDA approved updated labeling last year for Stamford, Connecticut-based Purdue's OxyContin that indicates it thwarts abuse and said it won't allow generic versions on the market ...
http://ift.tt/1F54ZBb
http://ift.tt/1F54ZBb
No comments:
Post a Comment